name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
R-HSA-1280218 Adaptive Immune System 746 22 2.87 5.4 5.3e-06 0.00067 3.45 2.03 5.62
R-HSA-199991 Membrane Trafficking 599 19 3.08 5.36 9.3e-06 0.00067 3.64 2.07 6.09
R-HSA-5653656 Vesicle-mediated transport 631 19 2.93 5.1 2e-05 0.00093 3.44 1.96 5.75
R-HSA-9006934 Signaling by Receptor Tyrosine Kinases 487 16 3.19 5.06 3.4e-05 0.0012 3.68 2 6.39
R-HSA-983169 Class I MHC mediated antigen processing & presentation 365 13 3.46 4.89 8.9e-05 0.0025 3.92 1.99 7.14
R-HSA-1660499 Synthesis of PIPs at the plasma membrane 51 5 9.53 6.23 0.00017 0.0034 10.9 3.32 28.2
R-HSA-1483255 PI Metabolism 78 6 7.48 5.86 0.00014 0.0034 8.44 2.93 20
R-HSA-983168 Antigen processing: Ubiquitination & Proteasome degradation 310 11 3.45 4.47 0.00033 0.0059 3.84 1.83 7.3
R-HSA-2219528 PI3K/AKT Signaling in Cancer 94 6 6.21 5.17 4e-04 0.0064 6.9 2.41 16.2
R-HSA-210993 Tie2 Signaling 18 3 16.2 6.58 0.00077 0.0095 19.8 3.61 71.4
R-HSA-442755 Activation of NMDA receptor and postsynaptic events 41 4 9.48 5.55 8e-04 0.0095 10.8 2.74 30.8
R-HSA-8853659 RET signaling 41 4 9.48 5.55 8e-04 0.0095 10.8 2.74 30.8
R-HSA-168256 Immune System 1970 34 1.68 3.42 0.00093 0.01 2.03 1.3 3.11
R-HSA-912631 Regulation of signaling by CBL 21 3 13.9 6.03 0.0012 0.013 16.5 3.06 57.8
R-HSA-512988 Interleukin-3, 5 and GM-CSF signaling 47 4 8.27 5.1 0.0013 0.013 9.26 2.37 26.2
R-HSA-912526 Interleukin receptor SHC signaling 27 3 10.8 5.2 0.0026 0.019 12.3 2.34 41.7
R-HSA-450282 MAPK targets/ Nuclear events mediated by MAP kinases 28 3 10.4 5.09 0.0029 0.019 11.9 2.25 39.8
R-HSA-186763 Downstream signal transduction 29 3 10.1 4.98 0.0032 0.019 11.4 2.17 38.1
R-HSA-399719 Trafficking of AMPA receptors 31 3 9.41 4.78 0.0039 0.019 10.6 2.03 35.1
R-HSA-399721 Glutamate binding, activation of AMPA receptors and synaptic plasticity 31 3 9.41 4.78 0.0039 0.019 10.6 2.03 35.1
R-HSA-114604 GPVI-mediated activation cascade 55 4 7.07 4.6 0.0024 0.019 7.81 2.01 21.9
R-HSA-187037 NGF signalling via TRKA from the plasma membrane 57 4 6.82 4.49 0.0027 0.019 7.51 1.94 21
R-HSA-450294 MAP kinase activation in TLR cascade 60 4 6.48 4.34 0.0033 0.019 7.11 1.84 19.8
R-HSA-8873719 RAB geranylgeranylation 64 4 6.08 4.15 0.0042 0.019 6.63 1.72 18.4
R-HSA-4420097 VEGFA-VEGFR2 Pathway 95 5 5.12 4.11 0.0029 0.019 5.56 1.73 13.9
R-HSA-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 96 5 5.06 4.08 0.003 0.019 5.5 1.71 13.8
R-HSA-166166 MyD88-independent TLR4 cascade  98 5 4.96 4.02 0.0033 0.019 5.38 1.67 13.4
R-HSA-937061 TRIF(TICAM1)-mediated TLR4 signaling  98 5 4.96 4.02 0.0033 0.019 5.38 1.67 13.4
R-HSA-194138 Signaling by VEGF 103 5 4.72 3.87 0.0041 0.019 5.11 1.59 12.7
R-HSA-199418 Negative regulation of the PI3K/AKT network 103 5 4.72 3.87 0.0041 0.019 5.11 1.59 12.7
R-HSA-166520 Signalling by NGF 147 6 3.97 3.7 0.004 0.019 4.28 1.51 9.9
R-HSA-1483257 Phospholipid metabolism 200 7 3.4 3.5 0.0045 0.02 3.67 1.42 8
R-HSA-1257604 PIP3 activates AKT signaling 254 8 3.06 3.39 0.0046 0.02 3.31 1.37 6.89
R-HSA-2219530 Constitutive Signaling by Aberrant PI3K in Cancer 68 4 5.72 3.98 0.0052 0.021 6.21 1.61 17.2
R-HSA-448424 Interleukin-17 signaling 68 4 5.72 3.98 0.0052 0.021 6.21 1.61 17.2
R-HSA-6794362 Protein-protein interactions at synapses 70 4 5.56 3.9 0.0058 0.023 6.02 1.56 16.6
R-HSA-449147 Signaling by Interleukins 454 11 2.36 3.01 0.0068 0.026 2.55 1.22 4.83
R-HSA-177929 Signaling by EGFR 40 3 7.29 4.06 0.0079 0.027 8 1.55 25.9
R-HSA-109704 PI3K Cascade 41 3 7.11 4 0.0085 0.027 7.79 1.51 25.2
R-HSA-1433557 Signaling by SCF-KIT 41 3 7.11 4 0.0085 0.027 7.79 1.51 25.2
R-HSA-112399 IRS-mediated signalling 42 3 6.94 3.94 0.0091 0.027 7.59 1.48 24.5
R-HSA-451927 Interleukin-2 family signaling 42 3 6.94 3.94 0.0091 0.027 7.59 1.48 24.5
R-HSA-1236394 Signaling by ERBB4 43 3 6.78 3.87 0.0097 0.027 7.4 1.44 23.9
R-HSA-380270 Recruitment of mitotic centrosome proteins and complexes 80 4 4.86 3.53 0.0092 0.027 5.23 1.36 14.4
R-HSA-380287 Centrosome maturation 80 4 4.86 3.53 0.0092 0.027 5.23 1.36 14.4
R-HSA-2029480 Fcgamma receptor (FCGR) dependent phagocytosis 81 4 4.8 3.5 0.0096 0.027 5.16 1.34 14.2
R-HSA-168142 Toll Like Receptor 10 (TLR10) Cascade 82 4 4.74 3.47 0.01 0.027 5.09 1.33 14
R-HSA-168176 Toll Like Receptor 5 (TLR5) Cascade 82 4 4.74 3.47 0.01 0.027 5.09 1.33 14
R-HSA-975871 MyD88 cascade initiated on plasma membrane 82 4 4.74 3.47 0.01 0.027 5.09 1.33 14
R-HSA-2454202 Fc epsilon receptor (FCERI) signaling 126 5 3.86 3.29 0.0096 0.027 4.13 1.29 10.2
R-HSA-166016 Toll Like Receptor 4 (TLR4) Cascade 127 5 3.83 3.27 0.0099 0.027 4.09 1.28 10.1
R-HSA-112315 Transmission across Chemical Synapses 224 7 3.04 3.14 0.0082 0.027 3.26 1.26 7.09
R-HSA-9006925 Intracellular signaling by second messengers 282 8 2.76 3.05 0.0085 0.027 2.96 1.23 6.16
R-HSA-112316 Neuronal System 356 9 2.46 2.85 0.011 0.029 2.64 1.16 5.28
R-HSA-2428928 IRS-related events triggered by IGF1R 46 3 6.34 3.7 0.012 0.03 6.88 1.34 22.1
R-HSA-1655829 Regulation of cholesterol biosynthesis by SREBP (SREBF) 47 3 6.21 3.65 0.012 0.03 6.72 1.31 21.5
R-HSA-2428924 IGF1R signaling cascade 47 3 6.21 3.65 0.012 0.03 6.72 1.31 21.5
R-HSA-2404192 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) 48 3 6.08 3.59 0.013 0.03 6.57 1.29 21
R-HSA-392451 G beta:gamma signalling through PI3Kgamma 48 3 6.08 3.59 0.013 0.03 6.57 1.29 21
R-HSA-74751 Insulin receptor signalling cascade 48 3 6.08 3.59 0.013 0.03 6.57 1.29 21
R-HSA-8856688 Golgi-to-ER retrograde transport 134 5 3.63 3.12 0.012 0.03 3.87 1.21 9.57
R-HSA-556833 Metabolism of lipids 696 14 1.96 2.66 0.012 0.03 2.13 1.11 3.79
R-HSA-1227986 Signaling by ERBB2 49 3 5.95 3.54 0.014 0.031 6.43 1.26 20.5
R-HSA-397795 G-protein beta:gamma signalling 51 3 5.72 3.44 0.015 0.031 6.16 1.21 19.6
R-HSA-975138 TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation 90 4 4.32 3.23 0.014 0.031 4.61 1.21 12.6
R-HSA-166058 MyD88:Mal cascade initiated on plasma membrane 92 4 4.23 3.17 0.015 0.031 4.51 1.18 12.3
R-HSA-168181 Toll Like Receptor 7/8 (TLR7/8) Cascade 92 4 4.23 3.17 0.015 0.031 4.51 1.18 12.3
R-HSA-168188 Toll Like Receptor TLR6:TLR2 Cascade 92 4 4.23 3.17 0.015 0.031 4.51 1.18 12.3
R-HSA-975155 MyD88 dependent cascade initiated on endosome 92 4 4.23 3.17 0.015 0.031 4.51 1.18 12.3
R-HSA-380320 Recruitment of NuMA to mitotic centrosomes 93 4 4.18 3.14 0.015 0.031 4.46 1.17 12.2
R-HSA-8856828 Clathrin-mediated endocytosis 140 5 3.47 3 0.015 0.031 3.69 1.15 9.13
R-HSA-168179 Toll Like Receptor TLR1:TLR2 Cascade 95 4 4.09 3.09 0.016 0.032 4.36 1.14 11.9
R-HSA-181438 Toll Like Receptor 2 (TLR2) Cascade 95 4 4.09 3.09 0.016 0.032 4.36 1.14 11.9
R-HSA-168138 Toll Like Receptor 9 (TLR9) Cascade 96 4 4.05 3.06 0.017 0.033 4.31 1.13 11.8
R-HSA-168164 Toll Like Receptor 3 (TLR3) Cascade 97 4 4.01 3.04 0.018 0.033 4.26 1.12 11.6
R-HSA-6811442 Intra-Golgi and retrograde Golgi-to-ER traffic 200 6 2.92 2.79 0.017 0.033 3.1 1.1 7.11
R-HSA-202424 Downstream TCR signaling 98 4 3.97 3.01 0.018 0.034 4.22 1.1 11.5
R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis 100 4 3.89 2.96 0.02 0.036 4.13 1.08 11.3
R-HSA-168898 Toll-Like Receptors Cascades 153 5 3.18 2.77 0.021 0.037 3.36 1.05 8.3
R-HSA-186797 Signaling by PDGF 58 3 5.03 3.14 0.022 0.038 5.37 1.06 17
R-HSA-112314 Neurotransmitter receptors and postsynaptic signal transmission 154 5 3.16 2.75 0.021 0.038 3.34 1.05 8.24
R-HSA-1280215 Cytokine Signaling in Immune system 678 13 1.86 2.38 0.021 0.038 2.01 1.02 3.63
